262. Therapeutic Suppression of the KRAS-MYC Oncogenic Axis in Human Pancreatic Cancer Xenografts With U1 Adaptor Oligonucleotide / RGD Peptide Conjugates
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33071-4
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2016
Authors
Publisher
Elsevier BV